Zomedica Corp. (NASDAQ:ZOM) | Finanzwire

Basculer en Français

10035	Companies
204380	Keywords
134700	Articles
108389	Press releases

Home
Companies
Zomedica Corp.

PRESS RELEASE

published on 01/04/2024 at 12:30, 2 years 2 months ago

Zomedica Announces Publication of Research Validating Better Patient Acceptance of PulseVet(R) Electro-hydraulic Shock Wave Therapy without Sedation Utilizing Novel “X-Trode” Handpiece
Zomedica Corp. announced the publication of an article validating the ability to better utilize PulseVet electro-hydraulic shock wave therapy in awake canine patients without sedation. The article describes the use of a novel shockwave trode, reinforcing current clinical evidence on the effectiveness of electro-hydraulic shock wave therapy for various indications. The article was written by Dr. Gina L. Joseph and team at Colorado State University and is available on Frontiers in Veterinary Science. In addition, CSU is evaluating PulseVet therapy for slowing the progression of canine osteoarthritis, with expected results later in 2024. The ability to treat patients without sedation using X-Trode is seen as a major advancement. Zomedica's Vice President of Clinical and Veterinary Affairs, Adrian Lock, expressed excitement for the upcoming study to further validate the therapy's efficacy. The company's CEO, Larry Heaton, believes the publication will accelerate the acceptance of shock wave therapy for small animal patients. PulseVet's shock wave therapy harnesses high-energy sound waves to stimulate cells, promoting healing growth factors. Zomedica's commitment to advancing veterinary care is evident through ongoing clinical studies and product innovations. The company's mission to address the unmet needs of clinical veterinarians underscores its dedication to animal welfare and better veterinary practice. For more information, readers can visit Zomedica's website.

Zomedica Corp PulseVet Electro-hydraulic Shock Wave Therapy Veterinary Health Company Canine Patients Electro-hydraulic Shock Wave Therapy
PRESS RELEASE

published on 12/18/2023 at 12:30, 2 years 2 months ago

Zomedica Announces Expansion of Market Opportunity for TRUFORMA(R) Diagnostic Platform with Launch of Three New Assays for Commonly Performed Diagnostic Tests for Canine Gastrointestinal Disease
PRESS RELEASE

published on 12/06/2023 at 12:30, 2 years 3 months ago

Zomedica Announces Presentation of Clinical Data in Support of New Indications for PulseVet Shock Wave Therapy at Annual Meeting of American Association of Equine Practitioners
Zomedica announces presentation of clinical data in support of new indications for Pulsevet shock wave therapy at annual meeting of American Association of Equine Practitioners

Zomedica Pulsevet Shock Wave Therapy Veterinary Health Clinical Data
PRESS RELEASE

published on 11/28/2023 at 12:30, 2 years 3 months ago

Zomedica to Present at Noble Capital Markets' 19th Annual Emerging Growth Equity Conference
PRESS RELEASE

published on 11/20/2023 at 12:30, 2 years 3 months ago

Zomedica to Present at the 35th Annual Piper Sandler Healthcare Conference
PRESS RELEASE

published on 11/13/2023 at 22:20, 2 years 4 months ago

Zomedica Announces Record Third Quarter 2023 Financial Results: Revenue up 31% to $6.3 Million; 69% Gross Margin, and $118 Million in Liquidity, while Making Strategic Acquisitions of Structured Monitoring Products and Qorvo Biotechnologies
PRESS RELEASE

published on 11/02/2023 at 11:30, 2 years 4 months ago

Zomedica to Report Third Quarter 2023 Financial Results and Provide Business Update on November 13 at 4:30 p.m. ET
PRESS RELEASE

published on 10/10/2023 at 06:00, 2 years 5 months ago

Zomedica to Participate in the Lytham Partners Fall 2023 Investor Conference
PRESS RELEASE

published on 10/05/2023 at 12:30, 2 years 5 months ago

Zomedica Announces Acquisition of TRUFORMA Platform Developer Qorvo Biotech LLC, Accelerating Timeline to Gain Control of Manufacturing and Research & Development
PRESS RELEASE

published on 09/14/2023 at 12:30, 2 years 6 months ago

Zomedica Announces Expansion of Market Opportunity for TRUFORMA(R) Diagnostic Platform with Launch of First-and-only Point of Care eACTH Assay for Diagnosis and Management of Cushing’s Disease in Horses

Accesswire

Published on 03/16/2026 at 14:00, 16 minutes ago

Magdalena Biosciences, a Joint Venture Between Jaguar Health and Filament Health, Initiates Preclinical Study of Coca for Appetite Suppression
Published on 03/16/2026 at 13:45, 31 minutes ago

iFabric Corp Provides Strong 2025 Revenue Estimate and 2026 Outlook
Published on 03/16/2026 at 13:30, 46 minutes ago

Ondas Completes Acquisition of Rotron Aerospace Ltd., Expanding Long-Range Propulsion Technologies for Advanced Unmanned Systems for Defense
Published on 03/16/2026 at 13:30, 46 minutes ago

An Asteroid Just Hit Earth - Where Did Everything Land? New Global Challenge Seeks Answers
Published on 03/16/2026 at 13:30, 46 minutes ago

Tactical Resources Signs Agreement to Acquire the Sierra Blanca Quarry and Tailings Access for the Peak Rare Earth Project

View all ACCESSWIRE

EQS Group

Published on 03/16/2026 at 14:04, 11 minutes ago

Sartorius launches next-generation platform to boost efficiency in cell therapy production
Published on 03/16/2026 at 13:56, 19 minutes ago

Amundi Physical Metals plc: UK Final Terms
Published on 03/16/2026 at 13:55, 20 minutes ago

Amundi Physical Metals plc: Final Terms
Published on 03/16/2026 at 13:54, 21 minutes ago

LAIQON receives ISO 27001 certification
Published on 03/16/2026 at 13:35, 40 minutes ago

Bitmine Immersion Technologies (BMNR) Announces ETH Holdings Reach 4.596 Million Tokens, and Total Crypto and Total Cash Holdings of $11.5 Billion

Les Echos

Published on 03/16/2026 at 08:30, 5 hours 46 minutes ago

CDA - Update on CDA' parks solarization program
Published on 03/13/2026 at 19:50, 2 days 18 hours ago

Availability of ENGIE’S 2025 Universal Registration Document
Published on 03/13/2026 at 18:05, 2 days 20 hours ago

Availability of the 2025 Universal Registration Document of OPmobility SE
Published on 03/13/2026 at 07:30, 3 days 6 hours ago

BIOPHYTIS PRESENTS ITS DEVELOPMENT PROGRAMS IN OBESITY AND SARCOPENIA AT THE ICFSR CONFERENCE
Published on 03/12/2026 at 18:00, 3 days 20 hours ago

NEW OR RENEWED AGREEMENTS BETWEEN EURAZEO AND CERTAIN FAMILY SHAREHOLDERS

View all LES ECHOS COMFI WIRE